Cite

    Qin, J., Liu, J., Wu, C., Xu, J., Tang, B., Guo, K., Chen, X., Liu, W., Wu, T., Zhou, H., Fang, M., & Wu, Z. (2020). synthesis and biological evaluation of (3/4-(pyrimidin-2-ylamino)benzoyl)-based hydrazine-1-carboxamide/carbothioamide derivatives as novel RXRα antagonists. Journal of enzyme inhibition and medicinal chemistry, 35, 880–896. http://access.bl.uk/ark:/81055/vdc_100105294971.0x000024